Brief: Avacta Group Announces FDA Agreement On Pivotal Trial Design For Ava6000
25/06/2026 07:49
BRIEF-Avacta Group Announces FDA Agreement On Pivotal Trial Design For Ava6000 June 25 (Reuters) - Avacta Group PLC AVCT.L:
FDA AGREEMENT ON PIVOTAL TRIAL DESIGN FOR AVA6000
SINGLE PIVOTAL TRIAL WITH PROGRESSION-FREE SURVIVAL AS PRIMARY ENDPOINT FOR FULL APPROVAL